Medicines Health Products Particular products Medicines Homeopathic medicines Herbal medicinal products Biological and biosimilar medicinal products Generic medicinal products Medical devices and their accessories Human body material Blood and blood products Raw materials Specially reglemented substances Grey area
04/09/2024 Limited availability of medicinal product based on peginterferon alfa-2a, solution for injection: recommendations for physicians (-specialists) and (hospital) pharmacists.
20/08/2024 Call to professionals responsible for materiovigilance: take part in European Commission survey on electronic instructions for use
06/08/2024 Warning: serious adverse reactions when administering the veterinary medicinal product Senvelgo (velagliflozin molecule) to cats suffering from diabetes
26/07/2024 PRAC July 2024 – New recommendations for GLP-1 receptor agonists and direct healthcare professional communication for glatiramer acetate containing products